Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
03/2005
03/17/2005WO2004083383A3 Globin variant gene methods and compositions
03/17/2005WO2004074434A3 Methods and compositions for administering therapeutic and diagnostic agents
03/17/2005WO2004044177A3 Expression profiling based on histocultures
03/17/2005US20050059598 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
03/17/2005US20050059152 Culturing mesenchymal primordial cell tissues isolated from cord blood into biological scaffolds for use in repairing damaged tissue; regenerative medicies; tissue repair and replacement; tissue engineering
03/17/2005US20050059151 Compositions and methods for priming monocytic dendritic cells and t cells for th-1response
03/17/2005US20050059128 Heme domain modified cytochrome p450 monooxygenase for use in hydroxylating linear alkanes using atmospheric dioxygen as an oxidant
03/17/2005US20050059087 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
03/17/2005US20050059049 Oligonucleotide sequences comprising single-stranded target-binding segment and regions of dyad symmetry for use diagnostic tools in genomic analysis
03/17/2005US20050059045 Labraries of optimized cytochrome P450 enzymes and the optimized P450 enzymes
03/17/2005US20050059038 Screening mixture and identifying modulators for treatment and prevention of cell proliferative, nervous system, inflammatory and eating disorders
03/17/2005US20050059034 Isolating bodiliy fluid, recovering genetic materials and screening for genetic disorders; restriction fragment length polymorphism; genetic diagnostic testing; genomic analysis; genetic mapping; bioinformatics
03/17/2005US20050059030 Using oligonucleotide probes comprising ribosomal sequence as tool in detection of methicillin resistant strains of bacteria; single nucleotide polymorphism
03/17/2005US20050059016 Structural motifs and oligomeric compounds and their use in gene modulation
03/17/2005US20050058658 Treatment for HIV infections by stimulation of immune response in subjects by immunotherapy using proteins with immune therapy response to treat viruses
03/17/2005CA2576406A1 Cell-based assays for determining drug action
03/17/2005CA2537995A1 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
03/17/2005CA2537798A1 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
03/17/2005CA2536015A1 Modified oligonucleotides for telomerase inhibition
03/16/2005EP1513397A2 Transgenic ungulates capable of human antibody production
03/16/2005EP0907737B1 Il-6 mutein
03/15/2005US6867851 Scanning of biological samples
03/15/2005US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
03/10/2005WO2005021734A2 Generation of hematopoietic chimerism and induction of central tolerance
03/10/2005WO2005021733A2 Methods and compositions for sirna expression
03/10/2005WO2005021732A2 Organic cooling medium and its uses
03/10/2005WO2005021731A2 Soluble analyte detection and amplification
03/10/2005WO2005021730A2 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
03/10/2005WO2005021729A2 Inhibiting cellular proliferation by way of mixed lineage kinases
03/10/2005WO2005021728A2 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
03/10/2005WO2005021726A2 Immunogenic hiv compositions and related methods
03/10/2005WO2005021725A2 Nucleic acid analysis method conducted in small reaction volumes
03/10/2005WO2005021723A2 Nucleic acid molecules from rice controlling abiotic stress tolerance
03/10/2005WO2005021722A2 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
03/10/2005WO2005021720A2 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
03/10/2005WO2005021719A2 Libraries of recombinant chimeric proteins
03/10/2005WO2005021718A2 Tubulin regulatory elements for use in plants
03/10/2005WO2005021717A2 Oligonucleotide sequestering agents and methods of use
03/10/2005WO2005021716A2 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005WO2005021715A2 Methods for improving growth and crop productivity of plants by adjusting plant hormone levels, ratios and/or co-factors
03/10/2005WO2005021713A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005WO2005021712A2 Modified molecular beacons
03/10/2005WO2005021711A2 Approach for obtaining monoclonal antibodies to cell surface proteins
03/10/2005WO2005021709A2 Cln101 antibodies
03/10/2005WO2005021708A2 Bisphosphonates for prophylaxis and therapy against bioterrorism agents
03/10/2005WO2005021707A2 Severe acute respiratory syndrome dna vaccine compositions and methods of use
03/10/2005WO2005021705A2 Citrus sesquiterpene synthase, methods of production and uses thereof
03/10/2005WO2005007823A3 Compositions, kits, and methods for stimulation of homologous recombination
03/10/2005WO2005007815A3 Hairpin-labeled probes and methods of use
03/10/2005WO2005003290A3 Methods and devices for determining a cell characteristic, and applications employing same
03/10/2005WO2005003288A3 Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof
03/10/2005WO2004092348A3 Method for production of oncolytic adenoviruses
03/10/2005WO2004090112A3 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
03/10/2005WO2004087888A3 Neurotransmitter signaling can regulate life span in c. elegans
03/10/2005WO2004087880A3 Compounds and their use to treat diabetes and related disorders
03/10/2005WO2004076651A3 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines
03/10/2005WO2004072244A9 Polymerase-based protocols for generating chimeric oligonucleotides
03/10/2005WO2004057017A3 Detection of small nucleic acids
03/10/2005WO2004046313A3 Methods and compositions for determining methylation profiles
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005US20050055735 Use of complement protein C3 and its derivatives in enhancing mammalian embryo development
03/10/2005US20050054847 Compositions and methods for preparing short RNA molecules and other nucleic acids
03/10/2005US20050054101 Automated cell culture system and process
03/10/2005US20050054093 Progenitor cell culture for use in regenerative medicine and treatment of heart, liver and pancreatic disorders; tissue engineering and repair
03/10/2005US20050054083 Automated laboratory for high-throughput biological assays and RNA interference
03/10/2005US20050054065 High-activity phytase compositions
03/10/2005US20050054032 Methods of decoupling reaction scale and protein synthesis yield in batch mode
03/10/2005US20050054022 Identifying compounds which modulate activity of fatty acid transport 5 (FATP5) for use in prevention and treatment of body weight, insulin resistance, dyslipidemia, fatty liver and cardiovascular disorders
03/10/2005US20050054020 Protein O-sulfonation
03/10/2005US20050053989 Libraries of recombinant chimeric proteins
03/10/2005US20050053985 Multimeric protein comprising cleavage-polyadenylation specificity factor for use in identifying modulator for treatment and prevention of cell proliferative disorders
03/10/2005US20050053957 Polynucleotide sequence detection assays
03/10/2005US20050053936 High-throughput transcriptome and functional validation analysis
03/10/2005US20050053922 Expression vector comprising nucleotide sequences coding mutated cap and rep viral proteins for use as gene transfer tools in heterologous gene expression; RNA interference
03/10/2005US20050053608 Using monoclonal antibody/maytansine fusion as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy
03/10/2005CA2538513A1 Soluble analyte detection and amplification
03/10/2005CA2537528A1 Organic cooling medium and its uses
03/10/2005CA2537509A1 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
03/10/2005CA2537505A1 Citrus sesquiterpene synthase, methods of production and uses thereof
03/10/2005CA2536588A1 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
03/10/2005CA2536067A1 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
03/10/2005CA2535816A1 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005CA2535527A1 Immunogenic hiv compositions and related methods
03/10/2005CA2530221A1 Modified molecular beacons
03/10/2005CA2529710A1 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005CA2526128A1 Severe acute respiratory syndrome dna vaccine compositions and methods of use
03/09/2005EP1451295A4 Methods for mutating genes in cells and animals using insertional mutagenesis
03/09/2005CN1592852A Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
03/09/2005CN1590551A Optimization of cell for endogenous gene activation
03/03/2005WO2005019436A1 Trichoderma composition
03/03/2005WO2005019435A2 Anti-cancer vaccines
03/03/2005WO2005019434A2 Serine protease inhibitors for treatment of bacterial infections
03/03/2005WO2005019433A2 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi
03/03/2005WO2005019432A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis
03/03/2005WO2005019431A2 Selective inhibition of toll-like receptor-2
03/03/2005WO2005019430A2 In vitro selection of aptamer beacons
03/03/2005WO2005019426A2 Gene cluster for fostriecin biosynthesis
03/03/2005WO2005019425A2 Heat stable variants of adenosine diphosphate glucose pyrophosphorylase
03/03/2005WO2005019424A2 Retroviral vector and cell-based assay for measuring the mutation rate of retroviruses employing same
03/03/2005WO2005019423A2 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 100